Introduction
Stroke has the third highest mortality rate of 160,000 individuals per year in the United States (Lloyd-Jones et al., 2010) . Despite considerable preclinical and clinical research efforts, tissue plasminogen activator (t-PA) is the only FDA-approved treatment for stroke. However, t-PA has a short therapeutic time window of ~3-4.5 h and limited number of patients qualified for this life saving therapy (3-5%) (Lloyd-Jones et al., 2010) . More than 700 drug candidates have been investigated and shown to be effective in preclinical stroke studies, however, the majority have failed at different phases of clinic trials (Durukan and Tatlisumak, 2007) . Since previous stroke trials have demonstrated that drugs targeting one or only a few signaling pathways fail to improve clinical outcome after stroke, drugs with multimodal actions have been suggested to overcome this challenge (Minnerup and Schabitz, 2009 ).
In stroke, the affected brain parenchyma develops discrete regions known as ischemic core and penumbra. At the core of the stroke lesion, cell death starts within minutes resulting in energy store depletion leading to ionic imbalance and severe metabolic failure (Durukan and Tatlisumak, 2007) . Penumbra surrounds the core area with limited collateral blood flow. As the injury progresses in penumbral tissue, additional cell death occurs, leading to neurological functional deficits or death.
Therefore, it is important to have a complete understanding of changes in biochemical cascades initiating cell death in penumbra in order to identify viable therapeutic targets for reducing injury progression and promoting recovery (Pestalozza et al., 2002) . This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on July 11, 2017 jpet.aspetjournals.org Downloaded from JPET #184127 6 For this study we chose to target multiple opioid receptors (OR), which consist of three major types: delta opioid receptor (DOR), mu opioid receptor (MOR), and kappa opioid receptor (KOR) (Lord et al., 1977) . Among a number of important functions, a great deal of interest has been focused on understanding of neuroprotective effects of different OR agonists during stroke. KOR agonists have been shown to modulate glutamate toxicity by inhibiting presynaptic glutamate release in vitro (Bradford et al., 1986) , via closure of N-type Ca 2+ channels and restriction of Ca 2+ entry into presynaptic terminals (Gross and Macdonald, 1987) .
Additionally, some studies suggested that κ receptor activation decreases release of nitric oxide by inhibiting N-methyl-D-aspartate-evoked nitric oxide synthesis in ischemic brain in vivo (Goyagi et al., 2003) . Recent reports have demonstrated that DOR agonists also exhibit neuroprotection by decreasing release of glutamate (Zhang et al., 2000) or attenuating oxidative damage (Yang et al., 2009 ) during ischemia.
The opioid system has been reported to be differentially expressed after cerebral ischemia (Boutin et al., 1999) . The density of DOR has been shown to decrease between 3 and 12h, and density of MOR and KOR after 12 h permanent MCAO (pMCAO) in mice (Boutin et al., 1999) . We hypothesize that during early ischemic injury, neuroprotective effects can be achieved through activation of DOR, MOR and KOR. Previous observations from our lab supported the above notion indicating that a non-selective OR agonist, biphalin, exhibited enhanced anti-edematous effects, compared to selective DOR, MOR, and KOR agonists in hippocampal slices subjected to OGD and these effects were reversed by Naloxone (Yang et al., 2011) .
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Biphalin is a dimeric enkephalin analogue (Tyr-D-Ala-Gly-Phe-NH-) 2 with potent, non-selective OR agonist activity. It has high affinity for MOR and DOR, and low affinity for KOR (Lazarczyk et al., 2010) , with ability to reach both spinal and supraspinal sites expressing MOR and DOR (Abbruscato et al., 1997) . Based on these pharmacologic and kinetic features, we hypothesize that biphalin can decrease edema formation and exhibit neuroprotective effects following ischemic stroke.
The mechanism of OR agonist neuroprotection in stroke is still not clear. Acute activation of OR can cause inhibition of protein kinase C (PKC) in neurons exposed to OGD condition (Liu et al., 2008) affecting the phosphorylation state and activity of various proteins including ion transporters. One such ion transporter, NKCC has been shown to play an important role in edema formation during stroke (Kahle et al., 2009 ).
Our lab and others have shown PKC-dependent regulation of NKCC activity during OGD conditions in brain endothelial cells (Vigne et al., 1994; Yang et al., 2006) . Thus, we construe that biphalin may also decrease ischemia-induced edema formation through inhibition of NKCC function by regulating PKC activity in neurons since NKCC has been shown to play a key role in cellular brain edema (Kahle et al., 2009 ).
In summary, the purpose of this study was to identify the neuroprotective effect of biphalin and elucidate its possible mechanism(s) via a well-characterized in vivo focal ischemic stroke model, MCAO and in vitro mouse primary neuronal cell culture model. 
In vivo MCAO Model
MCAO was performed using CD-1 male mice (25-30g) based on previously reported procedures (Yang et al., 2011 ) with a slight modification. In brief, surgery was performed using a Zeiss OPMI pico I surgical microscope (Carl Zeiss GmbH, Jena, Germany) on an S100 suspension system with a 3CCD Toshiba digital camera, connected to a high definition LCD television monitor via a Pinnacle movie box.
Temperature was maintained at 37 o C, controlled by the thermostatic blanket (TCAT-2DF, Physitemp, NJ, USA). The mice were anesthetized with 4% isoflurane in the induced phase by inhalation and maintained at 1-1.5 % isoflurane in a nitrous oxide/oxygen 70/30 mixture using a face mask and a SurgiVet vaporizer (Smiths Medical North America, Waukesha, WI). First, skull was exposed by a midline incision on head, and a needle Doppler probe (Moor Instruments, Wilmington, DE, USA) was placed on the skull directly over the territory of the left middle cerebral artery (MCA) perfusion area of the cortex (1mm posterior and 3mm lateral to bregma)
This article has not been copyedited and formatted. The final version may differ from this version. and baseline cerebral blood flow was measured. A midline incision was made at the neck about 1.5 cm long, the left carotid bifurcation and common carotid artery (CCA)
were isolated from the adjacent tissue. After the careful isolation of ECA branches of the occipital and the superior thyroid arteries, as well as the internal carotid artery (ICA) branch (the pterygopalatine artery), these arteries were exposed, electrocoagulated, and cut. The left CCA and ICA were carefully separated from the adjacent vagus nerve and connective tissue to prepare for clip application. After occlusion of CCA by a microclip, the left ECA was ligated, coagulated, and cut distally to the cranial thyroid artery and a 5-0 nylon monofilament suture for permanent and 6-0 for transient model with a round tip (0.2-0.25 mm) of 13 mm 5-0 nylon monofilament was introduced gently up to ~8.5-9 mm towards the origin of the MCA. Successful occlusion was verified by a laser Doppler flowmetry and the local cerebral blood flow in the left MCA territory declined to about 10-15% of the baseline.
After the successful occlusion, the nylon monofilament was secured in the place by ligation. Then, the incision was closed by microsurgical clips.
For the pMCAO model, the monofilament was kept in the vessel for 6 h. For the tMCAO model, after 60 min's occlusion, the incision was opened. The suture was withdrawn up to the left carotid bifurcation to allow the brain to be reperfused.
Animals were excluded from the experimental group if the cerebral blood flow did not recover up to 70% of baseline within 10 min after the start of reperfusion.
Reperfusion lasted for 24 hr with cages placed under a heating lamp for the first two hours to prevent hypothermia. hemisphere (Sydserff et al., 1996) . This comparison of both hemispheres gave the chance to use every mouse as its own control to minimize the inter-experimental error described previously (Sydserff et al., 1996) . 6-8 mice were utilized for each experiment group. To avoid the overestimation of infarcted area because of brain swelling, three measurements were made on each slice for calculation of the size of ). The infarct and edema ratio are presented by the percentage of the ipsilateral to the controlateral hemisphere.
Histological Staining
Fluoro-Jade C (FJC) is an anionic dye that specifically stains the soma and neurites of degenerating neurons by binding to a currently unknown basic substance in neuronal cells (Schmued et al., 2005) . Dihydroethidium (DHE) is a lipophlic cell permeable dye that is rapidly oxidized to ethidium in the present of free radical superoxide. Ethidium is fixed by intercalation into DNA. Hence, it is an indication of oxidant stress. Since 4'-6-Diamidino-2-phenylindole (DAPI) is a fluorescent stain that binds strongly to DNA, we used it to detect nuclei.
DHE was administered 1mg/kg in 1% dimethylsulfoxide by intraperitoneal injection 1 h before sacrificing the animals (Suh et al., 2008) . Mice were anesthetized with an overdose of isoflurane, followed by the intracardiac perfusion with 30 ml cold normal saline and 40 ml 4% paraformaldehyde in PBS (pH 7.4). 
Neurological Score Evaluation
Neurologic examinations were carried out just after 24 hr reperfusion in tMCAO.
The neurologic findings were scored on a four-point scale (Hara et al., 1996) . Mice were held gently by the tail, suspended above 50 cm above the desk and monitor the forelimb flexion, where score of 0 indicated no neurologic deficit, which mice extend both forelimbs toward the floor. Score 1: mild focal neurologic deficit (animal showed forelimb flexion), mice flexed the forelimb contralateral to the injured hemisphere without other abnormality. Then mice were put on a large sheet of soft, plastic paper, which mice and grip firmly by their claws. Holding the tail, gentle lateral pressure was used to push the mice behind the mice's shoulder until the forelimb slide several inches. The same maneuver was performed several times in each direction. Score 2: moderate focal neurologic deficit (decreased resistance to lateral push and forelimb flexion without circling); after this, mice were released and let them move freely to observe the circling behavior. Score 3: severe focal deficit (animal showed the same behavior as in grade 2, plus circling) (Hara et al., 1996) .
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Locomotor Activity Measurements
After treatments, behavioral activity assays were carried out using VersaMax animal monitors (Accuscan Instruments Inc., Columbus, OH, USA), which has been used to monitor stroke behavioral outcome using several locomotor parameters and behavioral deficits that are predictive of ischemic damage (Vendrame et al., 2004) .
The chamber cage was 42*42*30 cm, made of clear Plexiglas glass, with holes for ventilation. Infrared monitoring sensors were located every 2.5 cm along the perimeter and 2.5 cm above the bottom. Another two set of 16 sensors were located 8.0 cm above the bottom on the opposite sides. Data were collected and input into a VersaMax analyzer (Accuscan Instrument Inc.), which transferred the signals to the computer that run the VersaMax and Versadata programs. These programs tabulated and processed a variable parameters related to locomotor behavior. In our study, eight different locomotor parameters were collected every 4 min for 20 min, which has been proved to reflect behavioral changes associated with neurological deficits induced by MCAO previously (Vendrame et al., 2004) . Before the experiment, mice were put into the chamber to acclimate the environment. All the behavioral assays were carried out between 12:00 PM and 5:00 PM. Every group had 6-8 mice.
Sample Preparation for Western Blot
At the end of experiment, the 6 hr pMCAO animals were anaesthetized with overdose of isoflurane and euthanized by cervical dislocation. Brains were quickly removed after 6 hr of MCAO and sectioned into of 3mm thickness slices, naming as 
PKC Translocation and NKCC Expression Assay by Western Blots
Protein concentration of isolated cytosolic and particulate samples was determined using a BCA assay (Pierce, Rockford, IL, USA). Exactly 15ug of protein of sample was loaded and separated using an 8% tris-glycine polyacrylamide gel (Novex, San Diego, CA, USA). This method has been utilized previously for the analysis of Western blot imumoreactivity (Yang et al., 2006 Inc., Piscataway, NJ, USA.).
We used T4 monoclonal antibody to detect NKCC. This antibody was developed against the carboxy-terminal 310 amino acids of the human colonic NKCC and purchased from the Developmental Studies Hybridoma Bank (Iowa City, IA, USA), and the PVDF membranes were probed with NKCC antibody at a dilution of 1:200 in TBST with 5% milk. The secondary antibody utilized was anti mouse Ig G-horeradish peroxidase secondary antibody. The incubation, washing, and detection steps were same as above in the detection of PKC.
The density of the chemiluminescence band was quantified using Bio-Rad Quantity One software (version 4.5.2) (Bio-Rad Laboratories, Hercules, CA, USA).
Mouse Primary Cortical Neuronal Cultures
Mouse primary cortical neurons were isolated and cultured essentially as described (Yang et al., 2011 (Invitrogen Carlsbad, CA, USA) at 37°C in a humidified atmosphere of 5% CO 2 in air.
Half of the medium was replaced with fresh Neurobasal medium after overnight incubation, (+supplements), and refreshed likewise twice a week.
Cell Volume Measurements
For oxygen-glucose deprivation (OGD) treatment, seven or eight in-vitro day old primary cortical neurons were exposed to the Earle's Balanced Salt Solution (EBSS) ((in mM) 140 NaCl, 5.36 KCl, 0.83 MgSO 4 , 1.8 CaCl 2 , 1.02 NaH 2 PO 4 , 6.19 NaHCO 3 ,)
to create aglycemic condition. Hypoxia was induced as previously described (Yang et al., 2011) by placing the cells in a custom made hypoxic polymer glove box (Coy Laboratories, Grass Lake, MI) which was infused with 95% N 2 and 5% CO 2 and the temperature was maintained at 37 °C. Biphalin with or without non-selective opioid receptor antagonist naloxone (0.1 mM) (Sigma-Aldrich Corp, St. Louis, MO, USA)
were added to the EBSS at the start of OGD at the concentration of 0.01 nM.
Primary neurons grown in normal conditions (specified above) served as normoxic controls. Biphalin (0.01 nM) with or without non-selective opioid receptor 
Results

Effects of Biphalin on Brain Edema and Infarct Formation Induced by tMCAO
The ischemic brain hemisphere showed significant swelling compared with the controlateral hemisphere, indicating significant edema formation during stroke (data not shown). Treatment with biphalin (given to animals 10 min after reperfusion at the concentration of 5.7 μmol/kg (i.p.)) decreased infarct formation in tMCAO, evidenced by TTC staining (Fig 1 A) . The infarct ratio was decreased by 52.2% 
Effects of Biphalin on Brain Edema and Infarct Formation Induced by pMCAO
Treatment with biphalin (given to animals 60 min after occlusion at the concentration of 5.7 μmol/kg (i.p.)) decreased infarct formation in pMCAO, evidenced by TTC staining (Fig 2 A) . The infarct ratio was significantly decreased with biphalin treatment (56.4% reduction P<0.05; Figure 
Effects of Biphalin on Neurological Damage after tMCAO Model
Neurological evaluation was carried out in tMCAO groups. Biphalin 
Locomotor Activity Measurement
A set of locomotor activity parameters were monitored by a Versa Max Figure 5B ). In contrast to the penumbra area, the cytosolic and particulate (membrane) protein expression of the conventional PKC isoforms PKC did not significantly increase or decrease in the ischemic core area.
Effects of Biphalin in Decreasing the Expression of NKCC
In the vehicle treated group subjected to pMCAO, the particulate (membrane) fraction expression of NKCC was significantly increased in penumbral brain area, compared with sham animal group (P<0.01; figure 6 ). With biphalin treatment, NKCC expression was significantly decreased compared with the vehicle treated group. We did not observe significant change in the expression of NKCC in core brain areas with vehicle treatment or biphalin treatment group. This article has not been copyedited and formatted. The final version may differ from this version. , and Cl -causes cytotoxic edema (Durukan and Tatlisumak, 2007) . Intracellular calcium overload upon onset of injury via calcium channels and intracellular release from the endoplasmic reticulum, mitochondria, synaptic vesicles, etc., causes enhanced activation of PKC, PLA2, PLC and in turn activates various proteases and endoncleases, further leading to BBB disruption, membrane phospholipid degradation, generation of reactive oxygen species, eventually causing apoptosis and necrosis (Durukan and Tatlisumak, 2007) . Furthermore, excitatory amino acids, especially glutamate, are released to further increase the intracellular Ca
Effects of Biphalin in Decreasing the Cell Volume in Primary Neuronal
2+
, Na + and Cl -levels which amplify the ischemic damage.
Classically, OR activation has been shown to result in the inhibition of calcium entry via reducing voltage gated L-type (Moises et al., 1994) , N-type and P-type calcium channels (Gross and Macdonald, 1987) . Meanwhile, this activation exhibits the inhibition of glutamate release and response in cultured neuronal cells (Zhu and This article has not been copyedited and formatted. The final version may differ from this version. Pan, 2005) . In the present study, we administrated biphalin (i.p. 5.7 μmol/kg) in pMCAO and tMCAO animals 60 min after the occlusion and 10 min after reperfusion, respectively. It is important that we tested the neuroprotective effect of biphalin at a clinically relevant time window (post ischemia). To detect the ischemic core tissue, we utilized TTC staining as a marker of tissue dehydrogenase and mitochondrial dysfunction. We also utilized FJC staining to detect progression of neurodegeneration and DHE staining to assess free radical damage in penumbral tissue. As expected, biphalin not only decreased neurodegeneration but also reduced free radical damage in penumbra areas in cortex, hippocampus and striatum, as shown by FJC and DHE staining in tMCAO (Figure 4 ). The free radical scavenging effect of OR activation could be supported by the previous reports showing decreased nitric oxide production via reducing glutamate release (Goyagi et al., 2003) or increased activity of antioxidant enzyme (SOD and GSH-Px) (Yang et al., 2009 ) after OR activation.
Since the behavioral changes after stroke have the high relevance with respect to patient recovery, we assessed the neurological functional improvement in biphalin treated stroke animals by classical neurological score method as well as VersaMax animal monitoring system. The qualitative assessment of animals using classical neurological deficit score was further confirmed with various quantitative assessments of locomotor functions, which might not be evident from merely assigning scores by the classical method. Biphalin treatment significantly improved not only neurological function but also locomoter parameters, including horizontal activity, total distance, number of movements, movement time, stereotype counts and center distance, etc., Many investigative compounds belonging to different pharmacological classes have been shown to exhibit neuroprotective effects, using preclinical MCAO models.
However, most studies dealt with the infarct volume rather than brain edema.
Nevertheless, enclosed brain structures and the paucity of lymphatic drainage within the cranium make the brain particularly sensitive to small changes in brain water.
Brain edema is the predominant cause of neurologic deterioration among the mass effects (Bounds et al., 1981) . Prolonged edema from brain ischemia can cause life threatening brain herniation of the vital structures. The clinical administration of mannitol and glycerol is restricted to the early stage of stroke, before BBB breakdown and exhibits the major drawbacks, such as rebound intracranial pressure or increase in cerebral volume with the secondary edema (Goluboff et al., 1964; Larsson et al., 1976) . Very limited drug candidates have been evaluated targeting brain edema during stroke. In regard to opioid agonists, activation of KOR by U 50 488 decreased brain edema after ischemia (Gueniau and Oberlander, 1997) . With need for new drug candidates, we decided to evaluate multiple benefits of the non-selective opioid agonist biphalin, in producing neuroprotective effects as well as anti-edematous effects in both tMCAO and pMCAO stroke models. In our previous studies, we demonstrated superior anti-edematous effects of biphalin compared to selective OR agonists, including κ selective agonist U50 488, using in vitro-hippocampal slice perfusion model (Yang et al., 2011) . Also, in that study biphalin significantly decreased cell volume in primary neuronal cells subjected to OGD which was reversed using Naloxone. Observations in this study are in good correlation with the previous results using a hippocampal slice perfusion model (Yang et al., 2011) .
To understand possible mechanisms of neuroprotection as well as antiedematous effects of biphalin, we studied the effect of OR activation on PKC expression. Several investigators have identified that acute activation of ORs decreases PKC activity (Liu et al., 2008) . Moreover, PKC inhibition have been shown to be neuroprotective in stroke (Bright and Mochly-Rosen, 2005) . In our study, we demonstrated PKC expression in two distinct brain injury areas, core and penumbra. We observed that biphalin reduced the translocation of three conventional isoforms of PKC in penumbra and activity (Abbruscato et al., 2004) . In the future, we plan to investigate these two possible pathways.
To further decipher the anti-edematous and neuroprotective effects of biphalin, we investigated changes in NKCC expression in penumbral brain areas. Brain edema formation mainly involves ion transporter dysfunction. Widely studied, NKCC has been implicated to play a key role in edema formation during ischemia (O'Donnell, 1993) . This view is supported by studies of Chen et al., demonstrating that NKCC1 knockout mice exhibited 40% reduction in infarct area and 1.1% reduction in water content of brain (Chen et al., 2005) . Increased NKCC activity and expression were generally shown to be associated with increased phosphorylation (Kahle et al., 2009) under both physiological as well as pathological conditions such as cerebral ischemia.
Our lab and others have shown that NKCC phosphorylation increased activity in endothelial cells during OGD conditions (Yang et al., 2006) and in cortex region in rat cerebral focal MCAO model (Yan et al., 2003) , as well as in astrocytes cells under 2 hr OGD conditions (Lenart et al., 2004) . PKC regulates various protein activities by phosphorylation of serine and threonine residues. It is postulated that phosphorylation of NKCC is the main operative mechanism, which also regulates NKCC activity (Yang et al., 2006) . In our study, we found that the NKCC inhibitor, bumetanide conditions glutamate has been shown to stimulate neuronal NKCC1 activity by activation of NMDA and non-NMDA ionotropic receptors (Sun and Murali, 1998; Su et al., 2002) . Our observation of inhibition of PKC-dependent NKCC activity during ischemia is an additional mechanisms by which OR activation could produce antiedematous effects and provides new insight into these possible neuroprotective pathways.
Taken together, we report here that the dimeric enkephalin OR agonist, biphalin, exhibits neuroprotective effects in pMCAO and tMCAO in vivo models of stroke.
Biphalin not only decreases both infarct and edema ratios, but also reduces the number of dying neuronal cells in penumbra area associated with stroke. One possible mechanism of the neuroprotective effects of biphalin is through reduced PKC This article has not been copyedited and formatted. The final version may differ from this version. at ASPET Journals on July 11, 2017 jpet.aspetjournals.org Downloaded from
